|
Post by sla55 on Mar 8, 2018 13:36:50 GMT -5
|
|
|
Post by mytakeonit on Mar 8, 2018 14:05:23 GMT -5
YES !!! And I'll volunteer to be the first one to the finish line !!!
|
|
|
Post by aceton3 on Mar 8, 2018 14:15:19 GMT -5
At least the headline is positive.
|
|
|
Post by peppy on Mar 8, 2018 14:23:41 GMT -5
I wish the motley crew would look or talk about the medication. Then they could go into why afrezza isn't selling.? Afrezza. Rapid Acting analogs
|
|
|
Post by mnkdfann on Mar 8, 2018 14:47:01 GMT -5
For anyone too lazy to read all the way to the end, let me share the author's conclusion ... SPOILER ALERT SPOILER ALERT SPOILER ALERT "Can MannKind overcome the odds? Frankly, the answer is no. There's no compelling sign that Afrezza is about to go supernova to save MannKind from a date with bankruptcy court. All the company can do is keep diluting shareholders to push off this eventuality, and that's not an investment-worthy scenario."
|
|
|
Post by mytakeonit on Mar 8, 2018 15:34:36 GMT -5
Oh, but I did read the whole article. I'm excited because I know that this is a motley fool article ... AND, that the funds are still increasing their holdings of MNKD shares. So, whose lead should I follow? Motley Fool or Fund managers? Hmmm
|
|
|
Post by dreamboatcruise on Mar 8, 2018 16:52:58 GMT -5
What's the old cliche... "What's the quickest way to become a millionaire?... Invest $10 million in MNKD." Sorry... joke, not bashing. Hopefully the days of losing money are behind us.
|
|
|
Post by tz on Mar 8, 2018 17:52:13 GMT -5
I only read the headline and replaced the question mark with !!!!!
|
|